LDL-P Labcorp
LP(a) Lipoprotein(a)
LP(a) Lipoprotein(a)
- LDL size patterns, large low density LDL particles are described as pattern A, and small high density LDL particles are pattern B.
- A correspondence between higher triglyceride levels and higher levels of smaller, denser LDL particles and alternately lower triglyceride levels and higher levels of the larger, less dense ("buoyant") LDL.
- A stronger correlation between human clinically obvious cardiovascular events and quantitatively measured particle concentrations.
HDL
Total Cholesterols < 200
Triglyceride
1. Statin lipid-lowering medication
Consumer Reports Statins Update: Pravastatin Pravachol, Simvastatin Zocor
Reduction of heart attacks: Atorvastatin (Lipitor), Lovastatin (Altoprev), Pravastatin (Pravachol) Simvastatin (Zocor), Rosuvastatin (Crestor)
Trajenta 糖漸平 Linagliptin 5mg
You-jet 憂解 Zoloft Sertraline 50mg
Loata 羅達 Cilostazol 50mg
Xanax 贊安諾 Alprazolam 0.25mg
- A stronger correlation between human clinically obvious cardiovascular events and quantitatively measured particle concentrations.
HDL
Total Cholesterols < 200
Triglyceride
1. Statin lipid-lowering medication
Consumer Reports Statins Update: Pravastatin Pravachol, Simvastatin Zocor
Reduction of heart attacks: Atorvastatin (Lipitor), Lovastatin (Altoprev), Pravastatin (Pravachol) Simvastatin (Zocor), Rosuvastatin (Crestor)
Reduction of deaths: Atorvastatin (Lipitor), Pravastatin (Pravachol), Simvastatin (Zocor)
Muscle damage: hydrophilic statins (fluvastatin, rosuvastatin, pravastatin), are less toxic than lipophilic statins (atorvastatin, lovastatin, and simvastatin)
Crestor 冠脂妥 rosuvastatin 魯士定 10mg 39%-46%
Muscle damage: hydrophilic statins (fluvastatin, rosuvastatin, pravastatin), are less toxic than lipophilic statins (atorvastatin, lovastatin, and simvastatin)
Crestor 冠脂妥 rosuvastatin 魯士定 10mg 39%-46%
2. PCSK9
Alirocumab Praluent
Evolocumab Repatha
Trajenta 糖漸平 Linagliptin 5mg
You-jet 憂解 Zoloft Sertraline 50mg
Loata 羅達 Cilostazol 50mg
Xanax 贊安諾 Alprazolam 0.25mg
* Testing for Diabetes: Testing for Diabetes and Prediabetes: A1C goal < 7%, fasting - 99 100-125 126-, glucose tolerance 75g 2 hours -139 140-199 200-, diabetes 200, Prevention of type 2 diabetes
* Monitoring Your Blood Sugar, target range: before meals 80-130, 1-2 hours later < 180
* Monitoring Your Blood Sugar, target range: before meals 80-130, 1-2 hours later < 180
* Prediabetes A1c 5.7-6.4, impared Glucose tolerance test 140-199 75g glucose, Impaired fasting glucose 100/110-125
長效型胰島素/基礎胰島素 Insulin analog
daily: Insulin degludec Tresiba 諾胰保諾特筆; Insulin degludec/insulin aspart Ryzodeg 諾胰得諾特筆
weekly: Insulin icodec Awiqli; Insulin icodec/semaglutide
daily: Insulin degludec Tresiba 諾胰保諾特筆; Insulin degludec/insulin aspart Ryzodeg 諾胰得諾特筆
weekly: Insulin icodec Awiqli; Insulin icodec/semaglutide
Senseonics Eversense E3 90 days, XL 180 days, 365 days in 2025
Over The Counter OTC cgm Dexcom Stelo, Abbott Lingo
Over The Counter OTC cgm Dexcom Stelo, Abbott Lingo
